EGFR and neoplasm: Nevertheless, simultaneous targeting of EGFR and HER2 is postulated to have therapeutic benefits, since overexpression, mutations or inappropriate signaling through these receptors were shown to play critical roles in tumor progression and metastasis, and confer poor prognosis in various cancers37, 38, 39, 40, 41.